Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-656706
Filing Date
2016-07-25
Accepted
2016-07-25 17:22:19
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d219508ds3.htm S-3 305253
2 EX-5.1 d219508dex51.htm EX-5.1 5216
3 EX-23.2 d219508dex232.htm EX-23.2 1526
4 GRAPHIC g219508bcpg01.jpg GRAPHIC 7947
5 GRAPHIC g219508covpg01.jpg GRAPHIC 7914
6 GRAPHIC g219508txpg03.jpg GRAPHIC 107880
  Complete submission text file 0001193125-16-656706.txt   484121
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-212674 | Film No.: 161782706
SIC: 2834 Pharmaceutical Preparations